Radiopharmaceuticals are regarded as a key technology in modern cancer medicine. They combine precise diagnostics with targeted therapy and act directly in the tumour tissue. Panter is deliberately using the visit to research institutions and companies as a signal. Saxony wants to position itself as a European centre for radiopharmaceutical innovations in the long term.
The cluster systematically combines science, industrial production and specialised contract development at one location for the first time. Research at the Helmholtz Centre meets medium-sized companies and internationally active suppliers who are constantly investing in production and infrastructure. For the Free State of Bavaria, this is not only about medical progress, but also about high-quality jobs, export potential and technological sovereignty. The theme day therefore marks a clear political step. Radiopharmacy is being declared a strategic future field instead of a specialised topic. For Saxony as a business location, this is a new industrial policy signal with a long-term effect.
Press release from the "Saxon State Ministry of Economic Affairs, Labour, Energy and Climate Protection" dated 8 January 2026